Dylan R Edwards Selected Research

Tissue Inhibitor of Metalloproteinases

5/2011	MMP-1 drives immunopathology in human tuberculosis and transgenic mice.
4/2010	Expression profiles and clinical correlations of degradome components in the tumor microenvironment of head and neck squamous cell carcinoma.
8/2008	Matrix metalloproteinase 13 is induced in fibroblasts in polyomavirus middle T antigen-driven mammary carcinoma without influencing tumor progression.
12/2005	Mycobacterium tuberculosis, but not vaccine BCG, specifically upregulates matrix metalloproteinase-1.
1/2004	Expression profiling of metalloproteinases and their inhibitors in cartilage.
12/2003	Analyses of all matrix metalloproteinase members in leukocytes emphasize monocytes as major inflammatory mediators in multiple sclerosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dylan R Edwards Research Topics

Disease

33	Neoplasms (Cancer) 12/2018 - 10/2002
19	Neoplasm Metastasis (Metastasis) 11/2016 - 10/2002
17	Breast Neoplasms (Breast Cancer) 01/2019 - 04/2004
4	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2018 - 10/2004
4	Carcinogenesis 05/2015 - 07/2005
3	Adenocarcinoma 04/2021 - 05/2006
3	Inflammation (Inflammations) 05/2015 - 10/2005
3	Fibrosis (Cirrhosis) 01/2013 - 04/2001
3	Necrosis 09/2010 - 10/2008
3	Atherosclerosis 09/2009 - 12/2003
3	Carcinoma (Carcinomatosis) 08/2008 - 03/2003
3	Multiple Sclerosis 04/2008 - 12/2003
3	Glioma (Gliomas) 05/2007 - 03/2003
2	Prostatic Neoplasms (Prostate Cancer) 12/2018 - 12/2008
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2018 - 01/2017
2	Noninfiltrating Intraductal Carcinoma (DCIS) 01/2017 - 01/2014
2	Tuberculosis (Tuberculoses) 05/2011 - 12/2005
2	Granuloma 05/2011 - 06/2010
2	Infections 05/2011 - 06/2010
2	Melanoma (Melanoma, Malignant) 04/2008 - 03/2003
2	Lymphatic Metastasis 04/2008 - 05/2006
2	Wounds and Injuries (Trauma) 04/2007 - 07/2002
2	Idiopathic Pulmonary Fibrosis 05/2006 - 03/2006
2	Arthritis (Polyarthritis) 01/2005 - 10/2002
2	T-Cell Lymphoma (Lymphoma, T Cell) 10/2003 - 10/2002
1	Pancreatic Neoplasms (Pancreatic Cancer) 11/2016
1	Virus Diseases (Viral Diseases) 02/2016
1	Hypertension (High Blood Pressure) 02/2016
1	Disease Progression 01/2014
1	Leukocytosis (Pleocytosis) 01/2013
1	Capsule Opacification 12/2010
1	Intraoperative Complications 12/2010

Drug/Important Bio-Agent (IBA)

34	Matrix Metalloproteinases (MMPs)IBA 11/2016 - 04/2002
16	Peptide Hydrolases (Proteases)FDA Link 02/2016 - 03/2003
15	Metalloproteases (Metalloproteinases)IBA 05/2015 - 12/2003
10	DisintegrinsIBA 05/2015 - 01/2005
8	Proteins (Proteins, Gene)FDA Link 12/2018 - 07/2002
8	EnzymesIBA 05/2015 - 01/2005
7	ThrombospondinsIBA 05/2015 - 04/2004
6	Matrix Metalloproteinase 8 (Neutrophil Collagenase)IBA 01/2018 - 04/2008
6	Tissue Inhibitor of MetalloproteinasesIBA 05/2011 - 12/2003
5	Matrix Metalloproteinase InhibitorsIBA 05/2011 - 10/2002
5	CytokinesIBA 01/2010 - 08/2005
5	Messenger RNA (mRNA)IBA 09/2009 - 07/2005
4	Tissue Inhibitor of Metalloproteinase-3IBA 01/2013 - 04/2004
4	CollagenIBA 05/2011 - 04/2001
4	RNA (Ribonucleic Acid)IBA 09/2009 - 03/2003
3	Pharmaceutical PreparationsIBA 02/2016 - 05/2011
3	Membrane-Associated Matrix MetalloproteinasesIBA 09/2010 - 03/2003
3	LigandsIBA 05/2010 - 04/2005
3	Matrix Metalloproteinase 2 (Gelatinase A)IBA 03/2008 - 07/2002
3	GelatinasesIBA 03/2008 - 10/2002
3	Tissue Inhibitor of Metalloproteinase-1IBA 09/2007 - 04/2001
2	IntegrinsIBA 01/2018 - 01/2014
2	ChemokinesIBA 01/2018 - 06/2013
2	Matrix Metalloproteinase 9 (Gelatinase B)IBA 11/2016 - 07/2002
2	Interleukin-6 (Interleukin 6)IBA 11/2016 - 06/2013
2	CarcinogensIBA 01/2014 - 04/2008
2	Conditioned Culture MediaIBA 06/2013 - 06/2010
2	Epidermal Growth Factor (EGF)IBA 05/2011 - 05/2010
2	Cell Surface ReceptorsIBA 05/2011 - 05/2010
2	Matrix Metalloproteinase 14 (MT1-MMP)IBA 09/2010 - 05/2006
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2010 - 08/2005
2	Transforming Growth Factor beta1 (TGF beta 1)IBA 09/2009 - 05/2006
2	Protein Isoforms (Isoforms)IBA 01/2009 - 03/2008
2	TenascinIBA 01/2009 - 12/2006
2	Small Interfering RNA (siRNA)IBA 03/2008 - 12/2006
2	Tissue Inhibitor of Metalloproteinase-2IBA 12/2003 - 03/2003
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 03/2003 - 12/2002
1	Monoclonal AntibodiesIBA 04/2021
1	Claudin-1IBA 01/2019
1	P-2 (P 2)IBA 12/2018
1	Prostate-Specific Antigen (Semenogelase)IBA 12/2018
1	ProdrugsIBA 02/2016
1	Protease Inhibitors (Protease Inhibitor)IBA 02/2016
1	Metalloendopeptidases (Metalloendopeptidase)IBA 05/2015
1	ZincIBA 05/2015
1	Syndecan-4IBA 02/2015
1	Biomarkers (Surrogate Marker)IBA 10/2013
1	InterleukinsIBA 06/2013
1	Interleukin-8 (Interleukin 8)IBA 06/2013
1	phthalocyanineIBA 05/2011
1	Fibrillar CollagensIBA 05/2011
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 05/2011
1	Ro 32-3555IBA 05/2011
1	GoldIBA 05/2011
1	SERPIN-B5 (maspin)IBA 11/2010
1	Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA 11/2010
1	SerpinsIBA 11/2010
1	ICT 2552IBA 09/2010
1	ICT2588IBA 09/2010
1	Doxorubicin (Adriamycin)FDA LinkGeneric 09/2010
1	Oxygen (Dioxygen)IBA 09/2010
1	NF-kappa B (NF-kB)IBA 06/2010
1	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 06/2010

Therapy/Procedure

12	Therapeutics 12/2018 - 10/2003
1	Prostatectomy (Retropubic Prostatectomy) 12/2018
1	Drug Therapy (Chemotherapy) 01/2017
1	Photochemotherapy (Photodynamic Therapy) 05/2011
1	Lenses 12/2010